Proheptazine
 | |
| Systematic (IUPAC) name | |
|---|---|
| 1,3-dimethyl-4-phenylazepan-4-yl propionate | |
| Clinical data | |
| |
| Identifiers | |
| 77-14-5 | |
| None | |
| PubChem | CID 60969 |
| ChemSpider |
54931  |
| UNII |
S23189WW7E |
| Chemical data | |
| Formula | C17H25NO2 |
| 275.39 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Proheptazine is an opioid analgesic from the phenazepine family. It was invented in the 1960s.[1]
Proheptazine produces similar effects to other opioids, including analgesia, sedation, euphoria, dizziness and nausea.
In the United States it is a Schedule I Narcotic controlled substance with an ACSCN of 9643 and a 2013 annual aggregrate manufacturing quota of zero.
References
- ↑ Diamond J, Bruce WF, Tyson FT. Synthesis and Properties of the Analgesic DL-α-1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane (Proheptazine). Journal of Medicinal Chemistry. 1964 Jan;7:57-60.